NFA
ANIK icon

Nationwide Fund Advisors’s Anika Therapeutics ANIK Stock Holding History

Nationwide Fund Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-30,552
Closed -$1.77M – 122
2017
Q3 		$1.77M Sell
30,552
-856
-3% -$44.7K 0.01% 1498
2017
Q2 		$1.55M Buy
31,408
+9,780
+45% +$450K 0.01% 1547
2017
Q1 		$940K Sell
21,628
-237
-1% -$11.3K ﹤0.01% 1788
2016
Q4 		$1.07M Buy
21,865
+377
+2% +$17.4K ﹤0.01% 1735
2016
Q3 		$1.03M Sell
21,488
-830
-4% -$41K ﹤0.01% 1770
2016
Q2 		$1.2M Sell
22,318
-1,167
-5% -$55K 0.01% 1616
2016
Q1 		$1.06M Sell
23,485
-533
-2% -$21.6K ﹤0.01% 1684
2015
Q4 		$917K Buy
24,018
+998
+4% +$38.2K ﹤0.01% 1775
2015
Q3 		$733K Buy
23,020
+13,516
+142% +$471K ﹤0.01% 1888
2015
Q2 		$314K Sell
9,504
-1,102
-10% -$39.3K ﹤0.01% 2487
2015
Q1 		$437K Sell
10,606
-407
-4% -$16.5K ﹤0.01% 2302
2014
Q4 		$449K Sell
11,013
-148
-1% -$5.79K ﹤0.01% 2240
2014
Q3 		$409K Buy
11,161
+94
+0.8% +$4.06K ﹤0.01% 2321
2014
Q2 		$513K Buy
+11,067
New +$492K ﹤0.01% 2247
2014
Q1 		– Sell
-11,439
Closed -$437K – 3103
2013
Q4 		$437K Sell
11,439
-20,616
-64% -$636K ﹤0.01% 2298
2013
Q3 		$768K Buy
32,055
+20,658
+181% +$464K ﹤0.01% 1985
2013
Q2 		$194K Buy
+11,397
New +$164K ﹤0.01% 2495

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Nationwide Fund Advisors's ANIK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Anika Therapeutics (ANIK) in Q4 2017, closing a stake of 30,552 shares — an estimated $1.77M sold.

Nationwide Fund Advisors first reported a position in ANIK in Q2 2013 and held it in 17 quarters. The position peaked at $1.77M in Q3 2017. 172 funds tracked by Wall St. Rank hold ANIK as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Anika Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 30,552 Anika Therapeutics shares in Q4 2017, an estimated $1.77M.
  • Nationwide Fund Advisors first reported a position in Anika Therapeutics in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Anika Therapeutics position peaked at $1.77M in Q3 2017.
  • 172 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.